Limited-Access Zero-Contrast BASILICA Transcatheter Aortic Valve Replacement

Leo Kar Lok Lai1, Hussayn Alrayes1, Georgi Fram1

  • 1Center for Structural Heart Disease, Henry Ford Health System, Detroit, Michigan, USA.

JACC. Case Reports
|June 27, 2025
PubMed
Summary

This case study demonstrates a feasible zero-contrast agent BASILICA transcatheter aortic valve replacement (TAVR) approach for patients with contrast allergies, limited access, and high coronary occlusion risk. Multimodality imaging is crucial for success.